Atlas Trials

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Clinical trial NCT05731440 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05731440
Sponsor
Washington University School of Medicine
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Alzheimer Disease
Start date
2022-11-18
Primary completion
2027-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.